Sylvia Volksdorf
Merck & Co., Inc., Rahway, NJ, USA (United States)(US)
Publications by Year
Research Areas
Ion channel regulation and function, Nicotinic Acetylcholine Receptors Study, Pain Mechanisms and Treatments, Advanced biosensing and bioanalysis techniques, Cardiac electrophysiology and arrhythmias
Most-Cited Works
- → Analgesic Effects of a Substituted N-Triazole Oxindole (TROX-1), a State-Dependent, Voltage-Gated Calcium Channel 2 Blocker(2010)97 cited
- → Discovery of MK-1421, a Potent, Selective sstr3 Antagonist, as a Development Candidate for Type 2 Diabetes(2015)23 cited
- → Investigation of Cardiovascular Effects of Tetrahydro-β-carboline sstr3 antagonists(2014)13 cited
- → SAR exploration at the C-3 position of tetrahydro-β-carboline sstr3 antagonists(2016)9 cited